Canada: Federal Court Of Appeal Acknowledges "Non-Infringing Alternative" Defence For The First Time In The Assessment Of Damages For Patent Infringement

On July 23, 2015, the Federal Court of Appeal held that the availability of a non-infringing alternative may be a relevant consideration when assessing damages for patent infringement (2015 FCA 171). Nevertheless, the extent to which this decision will actually affect the quantum of damages awards in future patent infringement cases in Canada remains unclear.

The decision appealed

The Court of Appeal's decision overturns the reasoning of the 2013 decision of Snider J. of the Federal Court, who had held that the availability to a defendant of a non-infringing alternative (i.e., a product that could have been manufactured and sold in place of the infringing product manufactured and sold by the defendant) is not and should not be a relevant factor in the assessment of damages (2013 FC 751). In this regard, Snider J.'s decision was consistent with prior Federal Court decisions on this issue.

In this particular case, Snider J. found the defendants Apotex Inc. and Apotex Fermentation Inc. (collectively, "Apotex") liable for damages following their infringement of a product-by-process patent for the anti-cholesterol drug lovastatin owned by Merck & Co Inc. and licensed to Merck Canada Inc. (collectively, "Merck"). Apotex argued that the damages owed should be reduced because it had available to it a non-infringing alternative process for producing lovastatin that Apotex could and would have used had it not infringed. Snider J. dismissed this argument in a section spanning nearly 30 pages of her reasons. The point became the central issue on appeal.

Causation principles underlying the calculation of damages

Pursuant to the Canadian Patent Act, a person who infringes a patent is liable to the patentee for all damages he has sustained by reason of the infringement. Canadian courts have long held that this phrase "by reason of the infringement" invokes the principle of causation, i.e., scrutiny of the causal relationship between the wrongful conduct of the defendant and the injury suffered by the plaintiff. As such, a plaintiff-patentee is entitled to recoup all damages that it has established would not have occurred "but for" the defendant's infringement. Typically, this principle entitles the patentee to the hypothetical profits from the sales that it can establish it would have made "but for" the presence of the defendant's infringing product in the market.

Snider J. held that the fact "that the defendant could have used a non-infringing alternative (but did not)" was irrelevant to the foregoing analysis, as its proper focus ought to be on the infringer's actual actions and not its hypothetical actions.

In this respect, the Court of Appeal held that Snider J. erred and conflated the legal relevance of the non-infringing alternative with the availability of the non-infringing alternative in fact. Indeed, the Court of Appeal held that ignoring this consideration could actually over-compensate the patentee. That is, if damages for lost profits are calculated without regard to an available non-infringing alternative, the patentee would sometimes be better off than it would have been in the absence of infringement because, in the "but for" world, the infringer could and would have made and sold a non-infringing alternative that would have legitimately reduced the patentee's sales.

As such, in the Court of Appeal's view, achieving "perfect" compensation for the patentee requires consideration of (a) what, if any, non-infringing product the defendant or any other competitors could and would have sold "but for" the defendant's infringement and (b) the extent to which such lawful competition would have reduced the patentee's sales.

Other jurisprudence as support

In support of its analysis, the Court of Appeal cited jurisprudence from the U.S. as well as the Supreme Court of Canada and distinguished certain U.K. decisions that had previously been followed by Canadian courts.

In reviewing the U.S jurisprudence, the Court of Appeal noted that U.S. courts have held that if a non-infringing alternative that a defendant could and would have used, had it not infringed, is a true substitute and a real alternative to the infringing product, and would have replaced all infringing sales, the infringement causes the patentee to suffer no compensable damages, for two reasons. First, a truly fair and accurate reconstruction of the "but for" world must also take into account relevant, alternative actions that an infringer foreseeably could and would have undertaken had it not infringed. Second, only by comparing the patented invention to non-infringing alternatives can a court discern the market value of the patent owner's exclusive right and therefore its expected profit.

The Court of Appeal also cited the Supreme Court of Canada's decision in Monsanto Canada v Schmeiser (2004 SCC 34), which affirmed that the availability of a non-infringing alternative is relevant to the assessment of an accounting of the defendant's profits, an alternative remedy to a recovery of the plaintiff's damages in Canada. The Court of Appeal took the view that the same principle of causation underlies both remedies and, as such, there is no reason in principle to ignore the availability of a non-infringing alternative when calculating the patentee's lost sales.

The Court of Appeal also considered jurisprudence from the U.K., where, unlike the U.S., it has long been held that the availability of a non-infringing alternative is irrelevant to the assessment of damages for patent infringement. Prior Canadian decisions had followed this U.K. jurisprudence. However, the Court of Appeal found the U.K. law to be based on public policy rather than the principle of causation. In addition, the Court of Appeal found that the Canadian decisions that had followed the U.K. practice had inappropriately fixated on the defendant's actual conduct rather than its hypothetical conduct in the "but for" world and provided little by way of actual causation analysis. The Court of Appeal found that those earlier decisions "do not accord with the requirement in section 55(1) of the Patent Act that the damages be sustained 'by reason of the infringement'."

Policy rationale

Snider J. also rejected the relevance of a non-infringing alternative on the basis of several policy reasons, which generally centered on the view that considering this factor would result in inadequate compensation for the injured patentee and allow the infringer to escape responsibility for its infringement. As explained above, the Court of Appeal countered that consideration of this factor would actually result in "perfect compensation" – albeit less than the patentee might feel entitled to. Moreover, the availability of other remedies (e.g., elevated costs, injunctive relief for the remaining duration of the patent, an accounting of the infringer's profits, punitive damages) would in the Court of Appeal's view counterbalance any risk of immunity from liability or incentive to infringe.

Legal test to be applied

With these principles in mind, the Court of Appeal proposed a new legal test for determining the relevance of a non-infringing alternative based on the facts of a given case:

  1. Is the alleged non-infringing alternative a true substitute and thus a real alternative?
  2. Is the alleged non-infringing alternative a true alternative in the sense of 
  3. being economically viable?
  4. At the time of infringement, did the infringer have a sufficient supply of the non-infringing alternative to replace the non-infringing sales? Or rather, could the infringer have sold the non-infringing alternative? To satisfy this step, the alleged alternative must have been actually available to replace the infringing sales as they were made.
  5. Would the infringer actually have sold the non-infringing alternative? 

The burden lies on the defendant to establish the factual relevance of a non-infringing alternative pursuant to this framework on a balance of probabilities.

Application to the facts of the case

The Court of Appeal held that, on the one hand, Apotex had at all relevant times the capacity to manufacture and sell non-infringing lovastatin in sufficient quantities. On the other hand, Apotex failed to meet its burden of showing that, notwithstanding this capacity, it could and would have sold this non-infringing alternative in place of the infringing product.

Rather, at some point during the relevant time period, Apotex had ceased manufacturing operations of the non-infringing lovastatin, which would have taken several weeks to ramp up sufficiently again. As such, the alleged non-infringing alternative was not actually available to replace Apotex's infringing sales as they were made.

In any event, the Court of Appeal held that Apotex likely would not have replaced its infringing sales with sales of the non-infringing alternative because of, among other reasons: the scale of Apotex's infringement; its likely knowledge that its supplier was providing it with infringing lovastatin; its belief during the relevant time period that the Merck patent was invalid; its failure to adduce evidence that had it known the product was infringing it would have resurrected its manufacturing operations of the non-infringing alternative; and its failure to adduce evidence demonstrating that the profits it would have made from sales of the non-infringing alternative would have been greater than the value lost by reallocating resources to do so.

In light of these conclusions, the Court of Appeal held that the availability of a non-infringing alternative was not relevant on the facts of the case. As such, the appeal was dismissed – effectively upholding Snider J.'s decision, including the award of close to $120-million CAD in damages to Merck, plus interest, although guided by quite different reasoning.


As noted above, this decision is arguably a departure from past Canadian jurisprudence that had rejected the relevance of a non-infringing alternative in the assessment of damages for patent infringement. At the same time, the application of this analysis to the facts in the case highlights how difficult it may be for defendants to establish the existence and relevance of a non-infringing alternative in a particular case. Further understanding of the scope and effect of the decision will no doubt come with further decisions on patent infringement damages in Canada.

For further information, please contact a member of our firm's Litigation group.

The preceding is intended as a timely update on Canadian intellectual property and technology law. The content is informational only and does not constitute legal or professional advice. To obtain such advice, please communicate with our offices directly.

To print this article, all you need is to be registered on

Click to Login as an existing user or Register so you can print this article.

In association with
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Check to state you have read and
agree to our Terms and Conditions

Terms & Conditions and Privacy Statement (the Website) is owned and managed by Mondaq Ltd and as a user you are granted a non-exclusive, revocable license to access the Website under its terms and conditions of use. Your use of the Website constitutes your agreement to the following terms and conditions of use. Mondaq Ltd may terminate your use of the Website if you are in breach of these terms and conditions or if Mondaq Ltd decides to terminate your license of use for whatever reason.

Use of

You may use the Website but are required to register as a user if you wish to read the full text of the content and articles available (the Content). You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these terms & conditions or with the prior written consent of Mondaq Ltd. You may not use electronic or other means to extract details or information about’s content, users or contributors in order to offer them any services or products which compete directly or indirectly with Mondaq Ltd’s services and products.


Mondaq Ltd and/or its respective suppliers make no representations about the suitability of the information contained in the documents and related graphics published on this server for any purpose. All such documents and related graphics are provided "as is" without warranty of any kind. Mondaq Ltd and/or its respective suppliers hereby disclaim all warranties and conditions with regard to this information, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Mondaq Ltd and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use or performance of information available from this server.

The documents and related graphics published on this server could include technical inaccuracies or typographical errors. Changes are periodically added to the information herein. Mondaq Ltd and/or its respective suppliers may make improvements and/or changes in the product(s) and/or the program(s) described herein at any time.


Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:

  • To allow you to personalize the Mondaq websites you are visiting.
  • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our information providers who provide information free for your use.

Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.

If you do not want us to provide your name and email address you may opt out by clicking here .

If you do not wish to receive any future announcements of products and services offered by Mondaq by clicking here .

Information Collection and Use

We require site users to register with Mondaq (and its affiliate sites) to view the free information on the site. We also collect information from our users at several different points on the websites: this is so that we can customise the sites according to individual usage, provide 'session-aware' functionality, and ensure that content is acquired and developed appropriately. This gives us an overall picture of our user profiles, which in turn shows to our Editorial Contributors the type of person they are reaching by posting articles on Mondaq (and its affiliate sites) – meaning more free content for registered users.

We are only able to provide the material on the Mondaq (and its affiliate sites) site free to site visitors because we can pass on information about the pages that users are viewing and the personal information users provide to us (e.g. email addresses) to reputable contributing firms such as law firms who author those pages. We do not sell or rent information to anyone else other than the authors of those pages, who may change from time to time. Should you wish us not to disclose your details to any of these parties, please tick the box above or tick the box marked "Opt out of Registration Information Disclosure" on the Your Profile page. We and our author organisations may only contact you via email or other means if you allow us to do so. Users can opt out of contact when they register on the site, or send an email to with “no disclosure” in the subject heading

Mondaq News Alerts

In order to receive Mondaq News Alerts, users have to complete a separate registration form. This is a personalised service where users choose regions and topics of interest and we send it only to those users who have requested it. Users can stop receiving these Alerts by going to the Mondaq News Alerts page and deselecting all interest areas. In the same way users can amend their personal preferences to add or remove subject areas.


A cookie is a small text file written to a user’s hard drive that contains an identifying user number. The cookies do not contain any personal information about users. We use the cookie so users do not have to log in every time they use the service and the cookie will automatically expire if you do not visit the Mondaq website (or its affiliate sites) for 12 months. We also use the cookie to personalise a user's experience of the site (for example to show information specific to a user's region). As the Mondaq sites are fully personalised and cookies are essential to its core technology the site will function unpredictably with browsers that do not support cookies - or where cookies are disabled (in these circumstances we advise you to attempt to locate the information you require elsewhere on the web). However if you are concerned about the presence of a Mondaq cookie on your machine you can also choose to expire the cookie immediately (remove it) by selecting the 'Log Off' menu option as the last thing you do when you use the site.

Some of our business partners may use cookies on our site (for example, advertisers). However, we have no access to or control over these cookies and we are not aware of any at present that do so.

Log Files

We use IP addresses to analyse trends, administer the site, track movement, and gather broad demographic information for aggregate use. IP addresses are not linked to personally identifiable information.


This web site contains links to other sites. Please be aware that Mondaq (or its affiliate sites) are not responsible for the privacy practices of such other sites. We encourage our users to be aware when they leave our site and to read the privacy statements of these third party sites. This privacy statement applies solely to information collected by this Web site.

Surveys & Contests

From time-to-time our site requests information from users via surveys or contests. Participation in these surveys or contests is completely voluntary and the user therefore has a choice whether or not to disclose any information requested. Information requested may include contact information (such as name and delivery address), and demographic information (such as postcode, age level). Contact information will be used to notify the winners and award prizes. Survey information will be used for purposes of monitoring or improving the functionality of the site.


If a user elects to use our referral service for informing a friend about our site, we ask them for the friend’s name and email address. Mondaq stores this information and may contact the friend to invite them to register with Mondaq, but they will not be contacted more than once. The friend may contact Mondaq to request the removal of this information from our database.


This website takes every reasonable precaution to protect our users’ information. When users submit sensitive information via the website, your information is protected using firewalls and other security technology. If you have any questions about the security at our website, you can send an email to

Correcting/Updating Personal Information

If a user’s personally identifiable information changes (such as postcode), or if a user no longer desires our service, we will endeavour to provide a way to correct, update or remove that user’s personal data provided to us. This can usually be done at the “Your Profile” page or by sending an email to

Notification of Changes

If we decide to change our Terms & Conditions or Privacy Policy, we will post those changes on our site so our users are always aware of what information we collect, how we use it, and under what circumstances, if any, we disclose it. If at any point we decide to use personally identifiable information in a manner different from that stated at the time it was collected, we will notify users by way of an email. Users will have a choice as to whether or not we use their information in this different manner. We will use information in accordance with the privacy policy under which the information was collected.

How to contact Mondaq

You can contact us with comments or queries at

If for some reason you believe Mondaq Ltd. has not adhered to these principles, please notify us by e-mail at and we will use commercially reasonable efforts to determine and correct the problem promptly.